Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000530881 | SCV000647745 | uncertain significance | Familial adenomatous polyposis 1 | 2017-11-28 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with glutamic acid at codon 267 of the APC protein (p.Gly267Glu). The glycine residue is weakly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. This variant is present in population databases (rs747759906, ExAC 0.01%). This variant has not been reported in the literature in individuals with an APC-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV000575724 | SCV000667238 | uncertain significance | Hereditary cancer-predisposing syndrome | 2016-11-12 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: Insufficient or conflicting evidence,In silico models in agreement (benign) |
Color | RCV000575724 | SCV000681901 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-08-17 | criteria provided, single submitter | clinical testing |